Next Financial Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Next Financial Group’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Buy	+26	New	+$532	﹤0.01%	2690

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Next Financial Group's AMPH Position: Q4 2021 in Review

Next Financial Group opened a new position in Amphastar Pharmaceuticals (AMPH) in Q4 2021: 26 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2690 among its holdings.

168 funds tracked by Wall St. Rank hold AMPH as of Q4 2021.

Next Financial Group held 26 shares of Amphastar Pharmaceuticals worth $1K as of Q4 2021.
Amphastar Pharmaceuticals was a new Next Financial Group position in Q4 2021.
Amphastar Pharmaceuticals made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2690 holding.
168 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.